Results 231 to 240 of about 9,201,564 (391)

Embelin Mitigates the Impact of Perinatal Inflammation on Neuron Development by Inhibiting 5‐Lipoxygenase‐Mediated Ferroptosis

Phytotherapy Research, EarlyView.
ABSTRACT Neuronal development in newborns is often constrained by perinatal inflammation, with limited research available on the pathogenesis and treatment strategies for this condition. This study aimed to investigate the neuroprotective effects of Embelin in mitigating perinatal inflammation‐induced neuronal development limitations by targeting 5 ...
Feng Zhang, Mengya Sun, Shiyi Ma, Junfang Sun, Yishi Li, Xianghong Li, Hong Jiang   +6 more
wiley   +1 more source

Correction: Huntington Disease Health Related Quality of Life, Function and Well Being: The Patient's Perspective. [PDF]

Neurol Ther
Pérez-Pérez J, García-López S, Valle TF, Painous C, Querol-Pascual MR, Ruiz PJG, Diago EB, Cubo Delgado E, Pastor BV, Villaplana MCP, Santana IM, Blázquez Estrada M, Garride MC, Mir P, Álvarez C, Maurino J, de Prado A, López-Sendón JL.   +17 more
europepmc   +1 more source

Metabolomics: An Emerging "Omics" Platform for Systems Biology and Its Implications for Huntington Disease Research. [PDF]

Metabolites, 2023
Akyol S, Ashrafi N, Yilmaz A, Turkoglu O, Graham SF.   +4 more
europepmc   +1 more source

Nose‐to‐Brain Delivery of Acyl‐Ghrelin Peptide Gold Nanoconjugates for Treatment of Neurodegenerative Diseases

Small, EarlyView.
Intranasal delivery of acyl‐ghrelin using gold nanorods (AuNRs) is investigated as a strategy for treating neurodegenerative diseases. Acyl‐ghrelin is conjugated to AuNRs under optimized conditions that preserve its bioactivity and prevent nanoparticle cross‐linking.
Shunping Han, Rifka N. Utami, Yue Qin, Revadee Liam‐Or, Jemeen Sreedharan, Jeffrey S. Davies, Khuloud T. Al‐Jamal   +6 more
wiley   +1 more source

Protocol considerations for multigenerational blinding of preimplantation genetic testing for a monogenic condition for Huntington disease: a case report. [PDF]

F S Rep
Raine S, Siegel DR, Rabkina L, Nassab P, Cervero A, Martinez-Conejero JA, Elfman H, Polotsky AJ.   +7 more
europepmc   +1 more source

[Gene Therapy for Huntington Disease]. [PDF]

Fortschr Neurol Psychiatr, 2023
Bräuer S, Falkenburger B.
europepmc   +1 more source

Huntington Disease

, 2006
Alice Wexler
openalex   +1 more source

Reply to: “Refutation of the αSyn‐SAA‐Based Staging for Parkinson's Progression (Neuronal α‐Synuclein Disease‐Integrated Staging System [NSD‐ISS])”

Movement Disorders, EarlyView.
Tanya Simuni, Lana M. Chahine, Kathleen L. Poston, Catherine M. Kopil, Daniel Weintraub, Billy Dunn, Kenneth Marek   +6 more
wiley   +1 more source

Astrocyte Lipid Droplet Dynamics Orchestrate Neurological Disorders and Therapeutic Horizons

Small Science, EarlyView.
This review examines astrocyte lipid droplet (LD) metabolism in neurological disorders, including Alzheimer's disease, stroke, epilepsy, and glioma. It analyzes regulatory mechanisms governing LD formation, transport, and degradation in astrocytes, highlighting their potential as biomarkers and therapeutic targets through integrative multiomics ...
Jiani Zhong, Yanyi Peng, Lingyue Zhang, Bo Xiao, Mengqi Zhang   +4 more
wiley   +1 more source

Improving the Clinical Diagnostic Criteria for Genetically Confirmed Adult-Onset Huntington Disease: Considering Nonmotor Presentations. [PDF]

Neurol Clin Pract
Considine CM, Eddy CM, Frank SA, Kostyk SK, Oosterloo M, Killoran A, Furr Stimming E, Dose M, Cruickshank T, Bird TD, Vetter L, Arnesen A, Valvano J, Lange HW, Claassen DO.   +14 more
europepmc   +1 more source